ArticleCell communication and signaling : CCS2024

Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia.

Chuhong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.